2021
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

Ludwig Fischer von Weikersthal , Jan Hasenauer , Jan Hasenauer , Katrin Schierle
Journal of Clinical Oncology 39 ( 13) 1468 -1478

36
2021
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm.

Florian Lordick , Akihito Kawazoe , Yoshiaki Nakamura , Yelena Y Janjigian
Nature Reviews Clinical Oncology 1 -15

88
2021
Correction: Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?

Christoph Lübbert , Florian Lordick , Holger Kirsten , Amrei von Braun
PLOS ONE 16 ( 5)

2021
Importance of Systemic Chemotherapy in Advanced Peritoneal Metastasis

Florian Lordick , Thomas Golombek , Andreas Brandl
Springer International Publishing 239 -253

2021
Central validation of HER2 status to determine heterogeneity of marker expression in HER2-positive gastric cancer (GC).

Ivonne Haffner , Birgit Luber , Dieter Maier , Albrecht Kretzschmar
Journal of Clinical Oncology 35 12 -12

2017
Strong Association of a Common Dihydropyrimidine Dehydrogenase Gene Polymorphism with Fluoropyrimidine-Related Toxicity in Cancer Patients

Eva Gross , Birgit Busse , Matthias Riemenschneider , Steffi Neubauer
PLoS ONE 3 ( 12) e4003

80
2008
Recent advances in multimodal treatment for gastric cancer: a review.

Florian Lordick , J.Rüdiger Siewert
Gastric Cancer 8 ( 2) 78 -85

112
2005
Antibody-based targeted therapy for gastric cancer.

Florian Lordick , Christian Peschel , Jörg Rüdiger Siewert
Gastric Cancer 8 ( 4) 206 -208

14
2005
The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies.

Katja Ott , Florian Lordick , Ken Herrmann , Bernd-Joachim Krause
Gastric Cancer 11 ( 1) 1 -9

44
2008
8
2012
Optimal chemotherapy for advanced gastric cancer : is there a global consensus?

Florian Lordick , Sylvie Lorenzen , Yasuhide Yamada , David Ilson
Gastric Cancer 17 ( 2) 213 -225

123
2014
Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis.

Ulrike Heger , Franz Bader , Florian Lordick , Maria Burian
Gastric Cancer 17 ( 3) 478 -488

17
2014
Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

Kozo Kataoka , , Takahiro Kinoshita , Markus Moehler
Gastric Cancer 20 ( 5) 904 -912

18
2017
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

Katja Ott , Wolfgang A. Weber , Florian Lordick , Karen Becker
Journal of Clinical Oncology 24 ( 29) 4692 -4698

376
2006
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Takashi Kojima , Manish A Shah , Kei Muro , Eric Francois
Journal of Clinical Oncology 38 ( 35) 4138 -4148

456
2020
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

Christoph Schuhmacher , Stephan Gretschel , Florian Lordick , Peter Reichardt
Journal of Clinical Oncology 28 ( 35) 5210 -5218

434
2010